Skip to content

Network Analysis of Urinary Molecular Signature Complements Clinical Data to Predict Postoperative Acute Kidney Injury

Network Analysis of Urinary Molecular Signature Complements Clinical Data to Predict Postoperative Acute Kidney Injury Subtitle: Urinary Molecular and Metabolic Signature of Postoperative Acute Kidney Injury (NavigateAKI)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02114138
Acronym
NavigateAKI
Enrollment
240
Registered
2014-04-15
Start date
2015-07-31
Completion date
2030-12-31
Last updated
2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Keywords

postoperative acute kidney injury, pAKI, stress injury on the kidney, chronic kidney disease, CKD

Brief summary

The risk for postoperative acute kidney injury (pAKI), as for any other postoperative complications (PC), comes from a number of interactions between a patient's health before surgery, strength to tolerate surgery and influences on the operating room environment. At this time doctors do not have good tools to predict which patients may be at risk of having this complication. The purpose of this research study is to develop a urine test that can be used to predict the risk for having problems with kidney function after major surgery.

Detailed description

During hospitalization, a urine sample will be collected and additional tests will be added to the daily standard of care blood samples before, during and three times following an elective surgical procedure. Study participants will complete telephone interviews at 6 and 12 months after discharge from the hospital with a study team member. The telephone interview will consist of a short questionnaire asking about state of health and a health survey. At the same times of the phone interviews, the study team will mail a urine dipstick that is used to detect any amount of protein in the urine. Study participants will be asked to urinate on dipstick and send it back to the study team in provided shipping material. Healthy Controls will be enrolled to establish baseline values for kidney health based upon a single urine collection and a brief health questionnaire.

Interventions

PROCEDUREpathogenesis of perioperative acute kidney injury

understand pathogenesis of perioperative acute kidney injury in elective and emergent surgery

DIAGNOSTIC_TESTurine collection

urine collection will be performed on both the control group and hospitalized participants

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for Surgical Group: * Patients undergoing major in-hospital surgery * Planned hospital stay of at least 24 hours * Able to enroll prior to undergoing surgery

Exclusion criteria

for Surgical Group: * Patients not recruited 4 hours prior to undergoing surgery Inclusion Criteria for Healthy volunteers: \> 18 years old that elect to serve as a control group

Design outcomes

Primary

MeasureTime frameDescription
Occurrence of postoperative acute kidney injury (pAKI)up to 7 days after surgery.PostoperativeAKI is a change outcome of an increase of greater than or equal to 50% of creatinine from initial level prior to surgery until postoperative day 7.

Secondary

MeasureTime frameDescription
Change from baseline in urine protein biomarkers at 4 hours after surgeryBaseline, 4 hours after surgeryChange in urine protein biomarkers (urine insulin-like growth factor-binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinases-2 (TIMP-2)) from prior to surgery (baseline) to four hours after surgery.
Change from baseline in urine protein biomarkers at postoperative day 1Baseline, day 1 after surgeryChange in urine protein biomarkers (urine insulin-like growth factor-binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinases-2 (TIMP-2)) from prior to surgery (baseline) to postoperative day 1

Other

MeasureTime frameDescription
all cause mortalityup to 6 monthsTime-to-Event Outcome Measure followed for the duration of study enrollment and specifically measured at hospital discharge.
chronic kidney disease (CKD)12 months post-discharge from the hospital.This outcome will be assessed using urinary microalbumin/creatinine ratio (dipstick) mailed to study participants to urinate on and send back to the study team in provided shipping material at 12 months post-discharge from the hospital.
All cause mortality12 months post-discharge from the hospital.Time-to-Event Outcome Measure followed for the duration of study enrollment and specifically measured at 12 months post-discharge from the hospital.
Prolonged mechanical ventilationUp to 6 monthsTime-to-Event Outcome Measure taken when mechanical ventilation is greater than 48 hours during hospitalization.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026